The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Sponsored Symposium

[SS09]Young Pharmaceutical Scientists Pioneer Future Oligonucleotide Therapeutics

Fri. Mar 28, 2025 1:15 PM - 2:45 PM JST
Fri. Mar 28, 2025 4:15 AM - 5:45 AM UTC
Room 5 (Fukuoka International Congress Center: 202 [2F])
Sponsored by Transformative Research Area (B) “Cell Membrane Permeation of Oligonucleotides Controlled by Membrane Modulator Molecules”
Organizer: Takashi Osawa, (Grad. Sch. Pharm., Osaka Univ.) Yuuya Kasahara (NIBIOHN)
1:15 PM - 1:20 PM JST(4:15 AM - 4:20 AM UTC)

オーガナイザー挨拶・趣旨説明：大澤 昂志（阪大院薬）

1:20 PM - 1:31 PM JST(4:20 AM - 4:31 AM UTC)

[SS09-1]In vitro screening for the discovery of dipeptide ligands that enhance the activity of antisense oligonucleotides

○Takashi Osawa1, Ryosuke Kita1, Harumi Yamaguma2, Yuuya Kasahara1,2, Satoshi Obika1,3 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. OTRI, Osaka Univ.)
1:31 PM - 1:48 PM JST(4:31 AM - 4:48 AM UTC)

[SS09-2]Synthesis ofP-modified chimeric oligonucleotides for the development of oligonucleotide therapeutics having high safety and potency

○Kazuki Sato1, Yuhei Takahashi1, Takeshi Wada1 (1. Sch. Pharm. Sci., Tokyo University of Science)
1:48 PM - 2:05 PM JST(4:48 AM - 5:05 AM UTC)

[SS09-3]Technological improvements for antisense nucleic acid-loaded LNP preparation

○Hiroki Tanaka1,2, Hidetaka Akita1,2 (1. Grad. Sch. Pharm. Sci., Tohoku Univ., 2. CAMaD, Osaka Univ.)
2:05 PM - 2:22 PM JST(5:05 AM - 5:22 AM UTC)

[SS09-4]Development of oligonucleotide therapeutics for the radical cure for retro virus-related diseases

○Yu Mikame1, Haruki Toyama1, Chikara Dohno2, Takehiko Wada3, Asako Yamayoshi1,4 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. SANKEN, Osaka Univ., 3. IMRAM, Tohoku Univ., 4. Dept. Life Sci. Tech., Science Tokyo)
2:22 PM - 2:32 PM JST(5:22 AM - 5:32 AM UTC)

[SS09-5]Promotion of membrane permeation of biopharmaceuticals using coacervates

○Yoshimasa Kawaguchi1, Shiroh Futaki1 (1. Inst. Chem. Res., Kyoto Univ.)
2:32 PM - 2:43 PM JST(5:32 AM - 5:43 AM UTC)

[SS09-6]Establishment of a platform for the development of gapmer-type antisense oligonucleotides and the application of drug discovery for the intractable diseases

○Yuuya Kasahara1,2 (1. NIBIOHN, 2. Grad. Sch. Pharm. Sci., Osaka Univ.)
2:43 PM - 2:45 PM JST(5:43 AM - 5:45 AM UTC)

まとめ：笠原 勇矢（医薬健栄研）

Back to Category List